116 Views
The US Food and Drug Administration has advised manufacturers developing COVID-19 vaccines to develop shots tailored to the XBB.1.5 subvariant of coronavirus. Pfizer/BioNTech, Moderna and Novavax have already begun producing versions of their respective vaccines to target this and other currently circulating variants.
#COVIDVaccine #XBB1.5 #FDA
